These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12672542)

  • 1. Mouse models of Angelman syndrome, a neurodevelopmental disorder, display different brain regional GABA(A) receptor alterations.
    Sinkkonen ST; Homanics GE; Korpi ER
    Neurosci Lett; 2003 Apr; 340(3):205-8. PubMed ID: 12672542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
    Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
    PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased binding of [11C]flumazenil in Angelman syndrome patients with GABA(A) receptor beta3 subunit deletions.
    Holopainen IE; Metsähonkala EL; Kokkonen H; Parkkola RK; Manner TE; Någren K; Korpi ER
    Ann Neurol; 2001 Jan; 49(1):110-3. PubMed ID: 11198279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angelman syndrome reviewed from a neurophysiological perspective. The UBE3A-GABRB3 hypothesis.
    Dan B; Boyd SG
    Neuropediatrics; 2003 Aug; 34(4):169-76. PubMed ID: 12973656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion.
    Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM
    Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome.
    DeLorey TM; Handforth A; Anagnostaras SG; Homanics GE; Minassian BA; Asatourian A; Fanselow MS; Delgado-Escueta A; Ellison GD; Olsen RW
    J Neurosci; 1998 Oct; 18(20):8505-14. PubMed ID: 9763493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man.
    DeLorey TM; Olsen RW
    Epilepsy Res; 1999 Sep; 36(2-3):123-32. PubMed ID: 10515160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families.
    Nurmi EL; Bradford Y; Chen Y; Hall J; Arnone B; Gardiner MB; Hutcheson HB; Gilbert JR; Pericak-Vance MA; Copeland-Yates SA; Michaelis RC; Wassink TH; Santangelo SL; Sheffield VC; Piven J; Folstein SE; Haines JL; Sutcliffe JS
    Genomics; 2001 Sep; 77(1-2):105-13. PubMed ID: 11543639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAA receptor beta3 subunit gene-deficient heterozygous mice show parent-of-origin and gender-related differences in beta3 subunit levels, EEG, and behavior.
    Liljelund P; Handforth A; Homanics GE; Olsen RW
    Brain Res Dev Brain Res; 2005 Jun; 157(2):150-61. PubMed ID: 15878204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parental imprinting and Angelman syndrome.
    Lalande M; Minassian BA; DeLorey TM; Olsen RW
    Adv Neurol; 1999; 79():421-9. PubMed ID: 10514831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region.
    Sutcliffe JS; Jiang YH; Galijaard RJ; Matsuura T; Fang P; Kubota T; Christian SL; Bressler J; Cattanach B; Ledbetter DH; Beaudet AL
    Genome Res; 1997 Apr; 7(4):368-77. PubMed ID: 9110176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
    Colas D; Wagstaff J; Fort P; Salvert D; Sarda N
    Neurobiol Dis; 2005 Nov; 20(2):471-8. PubMed ID: 15921919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersociability in the Angelman syndrome mouse model.
    Stoppel DC; Anderson MP
    Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
    Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
    Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome.
    Egawa K; Kitagawa K; Inoue K; Takayama M; Takayama C; Saitoh S; Kishino T; Kitagawa M; Fukuda A
    Sci Transl Med; 2012 Dec; 4(163):163ra157. PubMed ID: 23220633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily.
    Nawaz Z; Lonard DM; Smith CL; Lev-Lehman E; Tsai SY; Tsai MJ; O'Malley BW
    Mol Cell Biol; 1999 Feb; 19(2):1182-9. PubMed ID: 9891052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
    Mulherkar SA; Jana NR
    Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome.
    Godavarthi SK; Dey P; Maheshwari M; Jana NR
    Hum Mol Genet; 2012 Apr; 21(8):1824-34. PubMed ID: 22215440
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wallace ML; van Woerden GM; Elgersma Y; Smith SL; Philpot BD
    J Neurophysiol; 2017 Jul; 118(1):634-646. PubMed ID: 28468997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.